Ati cautat: luare de mita

Protocol terapeutic: A16AX09 – GLYCEROLI PHENYLBUTYRAS (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)

Protocol terapeutic: B02AB02 – INHIBITOR ALFA 1 PROTEINAZA UMANA (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)

Protocol terapeutic: R07AX02 – DCI IVACAFTORUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: N07XX12 – DCI PATISIRANUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: M09AX01 – DCI ACIDUM HIALURONICUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L04AX04 – DCI LENALIDOMIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L02BB05 – DCI APALUTAMIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L01XX71 – DCI TISAGENLECLEUCEL (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L01XE26 – DCI CABOZANTINIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L01XC28 – DCI DURVALUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)